Author: Omar Al- Salem

Avalyn Pharma Inc., a biopharma company developing inhaled treatments for rare lung diseases, raised $300 million in a US initial public offering that priced at the top of its marketed range.

Source: Bloomberg, 4:40

Source: Bloomberg, 15:38

Source: Bloomberg, 0:00

Source: Bloomberg, 0:00

Source: Bloomberg, 5:40

King Charles III gathered leaders of some of the world’s biggest companies to encourage US-UK investment, as he swung through New York as part of a state visit aimed at shoring up ties between the two allies.

King Charles III gathered leaders of some of the world’s biggest companies to encourage US-UK investment, as he swung through New York as part of a state visit aimed at shoring up ties between the two allies.

Get caught up.

Source: Bloomberg, 0:00